First-in-human & early investigation
Research evaluating safety, feasibility, pharmacology, and early signals of activity for emerging approaches.

Westbrook's clinical research framework is intended to connect laboratory discoveries with studies that evaluate biomarkers, therapeutic strategies, disease monitoring, and patient-centered outcomes.
Clinical research programs can be organized around early scientific questions, translational validation, investigator-led studies, observational research, and collaborative clinical investigations.
Each study should be governed by appropriate scientific review, ethical oversight, informed consent requirements, and applicable regulations.
Eligibility for any future study would depend on the specific protocol. Study information should describe purpose, procedures, potential risks, benefits, alternatives, privacy considerations, and participation requirements.
Research evaluating safety, feasibility, pharmacology, and early signals of activity for emerging approaches.
Studies of molecular and measurable indicators that may help characterize disease and response.
Research connecting laboratory findings with human disease samples, models, and clinically relevant questions.
Investigation of treatment outcomes, survivorship, quality of life, and long-term cancer control.